Abstract |
Although muco-adhesive acyclovir 50mg tablets are only approved for the management of recurrent oro-labial HSV-1 infections, their ability to achieve extremely high concentrations in saliva and oral tissues suggests the potential for other uses. In this case, the agent was successfully utilized as a single tablet monotherapy leading to rapid clinical resolution of severe post-operative oro-labial infection. <p><em>J Drugs Dermatol. 2018;17(4):479-480.</em></p>.
|
Authors | Ted Rosen |
Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
Vol. 17
Issue 4
Pg. 479-480
(Apr 01 2018)
ISSN: 1545-9616 [Print] United States |
PMID | 29601626
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Adhesives
- Antiviral Agents
- Acyclovir
|
Topics |
- Acyclovir
(administration & dosage)
- Adhesives
(administration & dosage)
- Administration, Topical
- Adult
- Antiviral Agents
(administration & dosage)
- Female
- Herpes Labialis
(diagnosis, drug therapy)
- Herpes Simplex
(diagnosis, drug therapy)
- Humans
- Severity of Illness Index
- Treatment Outcome
|